Literature DB >> 18182040

Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors.

T Baglin1, C R Palmer, R Luddington, C Baglin.   

Abstract

BACKGROUND: The aim of the study was to determine the predictive value of D-dimer measurement for unprovoked recurrent venous thrombosis and the influence of sex, age and type of first event (unprovoked or provoked).
METHODS: Prospective cohort study of 272 patients with a first episode of venous thrombosis that was unprovoked or provoked by a non-surgical trigger.
FINDINGS: The cumulative rate of unprovoked recurrence in patients with a positive D-dimer was 20% at 5 years [5.5/100 patient-years, 95% confidence interval (CI) 3.7-7.8] and in patients with a negative D-dimer 17% (4.1/100 patient-years, 95% CI 2.3-6.9). The rates are not different (hazard ratio 1.3, 95% CI 0.7-2.5). After adjustment for clinical risk factors a positive D-dimer result was significantly associated with an increased risk of unprovoked recurrent thrombosis (hazard ratio 2.0, 95% CI 1.01-3.9). The strongest indicator of risk of recurrence was male sex (hazard ratio 3.3 unadjusted and 2.9 after adjustment). The only determinant of D-dimer in a linear regression model was age (P < 0.001).
CONCLUSIONS: The analysis indicates that clinical risk factors confound the association between D-dimer and risk of recurrence and when adjusted for these confounders a positive D-dimer result is significantly associated with unprovoked recurrence. The clinical utility of D-dimer measurement in individual patients should be interpreted in conjunction with clinical risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182040     DOI: 10.1111/j.1538-7836.2008.02889.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

Review 1.  Update in general internal medicine.

Authors:  Toshiko Uchida; Stephen D Persell; David W Baker
Journal:  J Gen Intern Med       Date:  2009-10-28       Impact factor: 5.128

2.  Retrospective review of D-dimer testing for venous thrombosis recurrence risk stratification: is this a useful test in the real world?

Authors:  Julie Wang; Mark Tacey; Prahlad Ho
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

3.  Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.

Authors:  Cristina Legnani; Michela Cini; Benilde Cosmi; Paolo Carraro; Armando Tripodi; Nicoletta Erba; Gualtiero Palareti
Journal:  Intern Emerg Med       Date:  2011-05-17       Impact factor: 3.397

4.  Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Aaron R Folsom; Alvaro Alonso; Kristen M George; Nicholas S Roetker; Weihong Tang; Mary Cushman
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

Review 5.  Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.

Authors:  James Douketis; Alberto Tosetto; Maura Marcucci; Trevor Baglin; Benilde Cosmi; Mary Cushman; Paul Kyrle; Daniela Poli; R Campbell Tait; Alfonso Iorio
Journal:  BMJ       Date:  2011-02-24

6.  D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.

Authors:  Gualtiero Palareti; Cristina Legnani; Emilia Antonucci; Benilde Cosmi; Daniela Poli; Sophie Testa; Alberto Tosetto; Walter Ageno; Anna Falanga; Piera Maria Ferrini; Vittorio Pengo; Paolo Prandoni
Journal:  Intern Emerg Med       Date:  2019-11-05       Impact factor: 3.397

7.  Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).

Authors:  Jayne Tullett; Ellen Murray; Linda Nichols; Roger Holder; Will Lester; Peter Rose; F D Richard Hobbs; David Fitzmaurice
Journal:  BMC Cardiovasc Disord       Date:  2013-03-09       Impact factor: 2.298

8.  Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach.

Authors:  Maura Marcucci; Alfonso Iorio; James Douketis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04

Review 9.  Recurrent venous thromboembolism: what is the risk and how to prevent it.

Authors:  Gualtiero Palareti
Journal:  Scientifica (Cairo)       Date:  2012-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.